Director of KSU Oncology Center. Mayo clinic trained myeloma doc at @_ksu. Interested in all plasma cell dyscrasia استاذ جامعي واستشاري
- Tweets8.2K
- Following520
- Followers1.2K
- Likes3.6K
ALT A quote from a Perspective published in the New England Journal of Medicine reads as follows: "Curative therapy is a remarkable achievement, but health systems should pursue possible future pathways to its deployment alongside these other measures, not ahead of them." The Perspective is titled "A Cure Out of Most Patients’ Reach — Sickle Cell Disease in the Gene-Therapy Era" and the authors are Naif I. AlJohani, M.D., M.H.C.M., and Sultan Almutairi, M.D. The text is displayed on a simple white background with a red border. The NEJM identity sits at the bottom.
ALT A figure from an Original Article published in the New England Journal of Medicine article titled "Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma." The figure shows Kaplan–Meier estimates of overall survival (intention-to-treat population). The trial name, ENDURANCE, is in parentheses after the title. The NEJM identity sits at the bottom.